Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator. Its mechanism of action is thought to involve direct relaxation of vascular smooth muscle, leading to peripheral vasodilation.
## Primary Indications
* Treatment of peripheral vascular diseases, such as arteriosclerosis obliterans, thromboangiitis obliterans (Buerger's disease), and Raynaud's disease.
* Adjunctive therapy for cerebrovascular insufficiency.
* Historically used for premature labor, but this use is no longer recommended due to safety concerns.
## Adult Dosing
* **Peripheral Vascular Disease:** 10 mg to 20 mg orally three to four times daily.
* **Cerebrovascular Insufficiency:** 10 mg to 20 mg orally three to four times daily.
* Maximum dose not clearly established in current literature, but doses exceeding 20 mg four times daily are generally not recommended.
## Pediatric Dosing
* No established pediatric dosing. Use is generally not recommended in children.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment. However, caution should be exercised in patients with significant organ dysfunction.
## Contraindications
* Hypersensitivity to isoxsuprine.
* Use immediately postpartum.
* Use in patients with congenital heart defects or in whom a rapid drop in blood pressure would be dangerous.
## Adverse Effects
* **Common:** Flushing, dizziness, weakness, nausea, vomiting, stomach upset, rash, headache.
* **Serious:** Hypotension, tachycardia, arrhythmias, blurred vision, chest pain.
## Key Drug Interactions
* **Antihypertensives:** May potentiate hypotensive effects.
* **Other Vasodilators:** Additive hypotensive effects.
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease improvement.
* Signs of adverse effects.
## Clinical Pearls
* Isoxsuprine is generally not considered a first-line agent for peripheral vascular disease due to limited efficacy and potential side effects.
* Oral administration may result in variable absorption.
* Its use for premature labor has been largely discontinued due to risks of maternal and fetal tachycardia and uterine atony.
***
**Disclaimer:** This information is intended for clinical decision support and does not replace professional medical judgment or a thorough review of the most current prescribing information and relevant literature. Always verify current drug information with official sources before prescribing or administering medications.
